Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sirna Therapeutics Inc (RNAI) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Sirna Therapeutics Inc. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 892112.
Total stock buying since 2005: $17,650,895.
Total stock sales since 2005: $0.
Total stock option exercises since 2005: $0.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2006 | 15,000 | $75,900 | 0 | $0 | 0 | $0 |
| 2005 | 10,984,373 | $17,574,995 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2006-05 | 15,000 | $75,900 | 0 | $0 | 0 | $0 |
| 2005-07 | 10,984,373 | $17,574,995 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2006-05-25 | Weaver Gregory L (Senior Vice President and CFO) | Buy | 15,000 | 5.06 | 75,900 |
| 2005-07-06 | Venrock Management Iii Llc (10% Owner) | Buy | 1,000,000 | 1.60 | 1,600,000 |
| 2005-07-06 | Vef Management Iii Llc (10% Owner) | Buy | 24,999 | 1.60 | 39,998 |
| 2005-07-06 | Roberts Bryan E (Director) | Buy | 1,249,999 | 1.60 | 1,999,998 |
| 2005-07-06 | Niedel James (Director) | Buy | 3,125,001 | 1.60 | 5,000,001 |
| 2005-07-06 | Greer R Scott (Director) | Buy | 37,500 | 1.60 | 60,000 |
| 2005-07-06 | Mrna Fund Ii Lp (10% Owner) | Buy | 1,250,000 | 1.60 | 2,000,000 |
| 2005-07-06 | Venrock Entrepreneurs Fund Iii Lp (10% Owner) | Buy | 24,999 | 1.60 | 39,998 |
| 2005-07-06 | Venrock Associates Iii Lp (10% Owner) | Buy | 1,000,000 | 1.60 | 1,600,000 |
| 2005-07-06 | Venrock Associates (10% Owner) | Buy | 225,000 | 1.60 | 360,000 |
| 2005-07-06 | Credit Suisse First Boston/ (Other) | Buy | 3,046,875 | 1.60 | 4,875,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of RNAI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Sirna Therapeutics Inc (symbol RNAI, CIK number 892112) see the Securities and Exchange Commission (SEC) website.